Transition metal compounds as cancer radiosensitizers
The concomitant administration of ionising radiation (IR) in the form of external beam radiotherapy or targeted radionuclide therapy (TRT) alongside radiosensitizing small molecules is a highly successful strategy for the treatment of cancer. The major clinical impact of the radiosensitizing platinu...
Hlavní autoři: | Gill, M, Vallis, K |
---|---|
Médium: | Journal article |
Vydáno: |
Royal Society of Chemistry
2018
|
Podobné jednotky
-
A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
Autor: Gill, M, a další
Vydáno: (2016) -
Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy
Autor: Lee, B, a další
Vydáno: (2019) -
111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
Autor: Gill, M, a další
Vydáno: (2018) -
Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy
Autor: Xiang-Yu Su, a další
Vydáno: (2014-06-01) -
Megavoltage radiosensitization of gold nanoparticles on a Glioblastoma Cancer Cell Line using a clinical platform
Autor: Kazmi, F, a další
Vydáno: (2020)